نتایج جستجو برای: attenuated vaccine

تعداد نتایج: 166073  

Journal: :The Iraqi Journal of Veterinary Medicine 2007

Journal: :American Journal of Public Health and the Nations Health 1962

Journal: :The Journal of Infectious Diseases 2005

Journal: :Vaccine 2009
Angelia A Eick Zhong Wang Hayley Hughes Stephen M Ford Steven K Tobler

Limited effectiveness data are available comparing live attenuated influenza vaccine (LAIV) to inactivated influenza vaccine (TIV) among adults. To compare the incidence of influenza-like illness following immunization of adults with LAIV vs. TIV, we conducted a retrospective cohort analysis of active component U.S. military personnel for the 2005-2006 and 2006-2007 influenza seasons. Recruits ...

2010
Robert B. Belshe Seth L. Toback Tingting Yi Christopher S. Ambrose

BACKGROUND It has been suggested that live attenuated influenza vaccine (LAIV) may be less effective in older individuals because of prior wild-type influenza infections. LAIV is currently approved in the United States, South Korea and Hong Kong for individuals 2-49 years of age. OBJECTIVE To examine data from previously published pediatric studies to determine the efficacy of LAIV in various...

2012
Angelia A. Eick-Cost Katie J. Tastad Alicia C. Guerrero Matthew C. Johns Seung-eun Lee Victor H. MacIntosh Ronald L. Burke David L. Blazes Kevin L. Russell Jose L. Sanchez

INTRODUCTION Following the 2009 influenza A/H1N1 (pH1N1) pandemic, both seasonal and pH1N1 viruses circulated in the US during the 2010-2011 influenza season; influenza vaccine effectiveness (VE) may vary between live attenuated (LAIV) and trivalent inactivated (TIV) vaccines as well as by virus subtype. MATERIALS AND METHODS Vaccine type and virus subtype-specific VE were determined for US m...

Journal: :Journal of virology 2014
David Hallengärd Maria Kakoulidou Aleksei Lulla Beate M Kümmerer Daniel X Johansson Margit Mutso Valeria Lulla John K Fazakerley Pierre Roques Roger Le Grand Andres Merits Peter Liljeström

UNLABELLED Chikungunya virus (CHIKV) is a reemerging mosquito-borne alphavirus that has caused severe epidemics in Africa and Asia and occasionally in Europe. As of today, there is no licensed vaccine available to prevent CHIKV infection. Here we describe the development and evaluation of novel CHIKV vaccine candidates that were attenuated by deleting a large part of the gene encoding nsP3 or t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید